Metraipolis › archive › dc_40f8bcb80b0e
Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review — Europe PMC PMID:42195096
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42195096
- DOI
- 10.3390/medicina62050843
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T14:52:40.372Z
- SHA-256 of the archived text
dfa3a73bb80e6fcf068608eb9d5f888d5f002d8d9f5970974ad0912934b00a42- Stable URL of this page
https://metraipolis.com/documento/dc_40f8bcb80b0e
How to cite
Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review — Europe PMC PMID:42195096 — Europe PMC (en), https://europepmc.org/article/MED/42195096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40f8bcb80b0e (Metraipolis archive dc_40f8bcb80b0e, sha256 dfa3a73bb80e6fcf068608eb9d5f888d5f002d8d9f5970974ad0912934b00a42)
BibTeX
@misc{dc40f8bcb80b0e,
title = {Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review — Europe PMC PMID:42195096},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42195096},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40f8bcb80b0e; sha256 dfa3a73bb80e6fcf068608eb9d5f888d5f002d8d9f5970974ad0912934b00a42},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195096. Agents can read the archived copy with the MCP tool read_document.